On-Demand Webinar: A New Era of Precision Medicine, Part II: Translating PGx Data and Infrastructure Considerations for Success
Recorded on: September 2022
Duration: 58 minutes
In this second part of a three-part webinar series, leading industry experts Amy Berk, Director of Population Health at Microsoft, Dr. David Kisor, Director of the Master of Science in Pharmacogenomics Program at Manchester University, and Dr. Robin Everts, Senior Manager of Global Pharmacogenetics & Clinical Genetics at Agena Bioscience®, discussed the importance of the infrastructure that is needed for a successful pharmacogenetics (PGx) initiative built for scalability, geographic reach, and regulatory oversight. This exciting event was hosted by GenXys‘ CMO, Dr. Bernard Esquivel, and is a must-see event for leaders in the industry looking to pave the way and accelerate their knowledge of PGx. Together, we discussed the crucial elements of how PGx data gets generated for a clinician in a purposeful way and the part that infrastructure plays as the cornerstone to creating a successful pharmacogenetics program.
We hope you enjoy!
Access The Recording
By submitting your email address, you also agree to receive the occasional email with awesome content on pharmacogenomics and precision medicine.
The information you provide us with is secure, we will not share your contact information with anyone.